Previous Section
Review Articles
81. Dopamine agonists in the treatment of Parkinson's disease.
- Author
- Bonuccelli U; Pavese N;
- Institution
- Department of Neuroscience, University of Pisa, (56126) Pisa, Italy. u.bonuccelli@med.unipi.it
- Journal
- Expert Rev Neurother. 2006 Jan;6(1):81-9.
- Abstract URL
- Click here to view abstract
82. Cholinesterase inhibitors for Parkinson's disease dementia.
- Author
- Maidment I; Fox C; Boustani M;
- Institution
- East Kent NHS and Social Care Partnership Trust, University of Kent, Trust HQ, Littlebourne Road, Canterbury, Kent, UK. ian.maidment@nhs.net
- Journal
- Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004747.
- Abstract URL
- Click here to view abstract
83. Cell transplantation for patients with Parkinson's disease.
- Author
- Paul G;
- Institution
- Neuronal Survival Unit, Experimental Medical Sciences, Wallenberg Neurocentrum, University of Lund, BMC A10, 22184 Lund, Sweden. gesine.paul@mphy.lu.se
- Journal
- Handb Exp Pharmacol. 2006;(174):361-88.
- Abstract URL
- Click here to view abstract
84. Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
- Author
- Pahwa R; Factor SA; Lyons KE; Ondo WG; Gronseth G; Bronte-Stewart H; Hallett M; Miyasaki J; Stevens J; Weiner WJ;
- Institution
- University of Kansas Medical Center, Kansas City, USA.
- Journal
- Neurology. 2006 Apr 11;66(7):983-95.
- Abstract URL
- Click here to view abstract
85. Psychosis in Parkinson's disease: case studies.
- Author
- Salter BC; Anderson KE; Weiner WJ;
- Institution
- Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21202, USA.
- Journal
- Neurol Clin. 2006 May;24(2):363-9.
- Abstract URL
- Click here to view abstract
86. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
- Author
- Zanetti R; Loria D; Rosso S;
- Institution
- Piedmont Cancer Registry, Center for Oncology, Turin, Italy. roberto.zanetti@cpo.it
- Journal
- Melanoma Res. 2006 Jun;16(3):201-6.
- Abstract URL
- Click here to view abstract
87. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease.
- Author
- Olanow CW; Obeso JA; Stocchi F;
- Institution
- Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA. warren.olanow@mssm.edu
- Journal
- Nat Clin Pract Neurol. 2006 Jul;2(7):382-92.
- Abstract URL
- Click here to view abstract
88. A comprehensive approach to Parkinson's disease. How to manage fluctuating motor and nonmotor symptoms.
- Author
- Brunton S;
- Institution
- Cabarrus/Northeast Medical Center Family Medicine, Charlotte, North Carolina, USA. ozdoc@aol.com
- Journal
- Postgrad Med. 2006 Jun-Jul;119(1):55-64.
- Abstract URL
- Click here to view abstract
89. Treatment of advanced Parkinson's disease.
- Author
- Diamond A; Jankovic J;
- Institution
- Movement Disorder Clinic, Colorado Neurologic Institute, 701 East Hampden Ave. Suite 330 Englewood, CO 80113, USA. Neurodoc01@sbcglobal.net
- Journal
- Expert Rev Neurother. 2006 Aug;6(8):1181-97.
- Abstract URL
- Click here to view abstract
90. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.
- Author
- Kleiner-Fisman G; Herzog J; Fisman DN; Tamma F; Lyons KE; Pahwa R; Lang AE; Deuschl G;
- Institution
- Parkinson's Disease Research Education and Clinical Center, Philadelphia VA Hospital, Philadelphia, Pennsylvania 19104, USA. galit.kleiner-fisman@med.va.gov
- Journal
- Mov Disord. 2006 Jun;21 Suppl 14:S290-304.
- Abstract URL
- Click here to view abstract
